Alvotech and Teva get US FDA approval of Selarsdi
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Fluid bed processes: drying, granulating, and coating in just one product container
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
The Product is expected to be the first generic approval on the market
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
The company plans to add 1700 beds by FY27 through the organic route
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Subscribe To Our Newsletter & Stay Updated